Reduced Thiamine Availability and Hyperglycemia Impair Thiamine Transport in Renal Glomerular Cells through Modulation of Thiamine Transporter 2

Thiamine helps transketolase in removing toxic metabolites, counteracting high glucose-induced damage in microvascular cells, and progression of diabetic retinopathy/nephropathy in diabetic animals. Diabetic subjects show reduced thiamine levels. Hyperglycemia and reduced thiamine availability concur in impairing thiamine transport inside the blood-retinal barrier, with thiamine transporter-2 (THTR2) primarily involved. Here, we examined the behavior of thiamine transporter-1 (THTR1), THTR2, and their transcription factor Sp1 in response to high glucose and altered thiamine availability in renal cells involved in diabetic nephropathy. Human proximal tubule epithelial cells, podocytes, glomerular endothelial, and mesangial cells were exposed to high glucose and/or thiamine deficiency/oversupplementation. Localization and modulation of THTR1, THTR2, and Sp1; intracellular thiamine; transketolase activity; and permeability to thiamine were examined. Reduced thiamine availability and hyperglycemia impaired thiamine transport and THTR2/Sp1 expression. Intracellular thiamine, transketolase activity, and permeability were strongly dependent on thiamine concentrations and, partly, excess glucose. Glomerular endothelial cells were the most affected by the microenvironmental conditions. Our results confirmed the primary role of THTR2 in altered thiamine transport in cells involved in diabetic microvascular complications. Lack of thiamine concurs with hyperglycemia in impairing thiamine transport. Thiamine supplementation could represent a therapeutic option to prevent or slow the progression of these complications.

[1]  M. Porta,et al.  Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy , 2019, Diabetes & vascular disease research.

[2]  K. Kankova,et al.  Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction. , 2017, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[3]  A. Paterson,et al.  Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes , 2015, Diabetes.

[4]  Katarína Kuricová,et al.  Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation? , 2014, World journal of diabetes.

[5]  Garry K. Brown.  Defects of thiamine transport and metabolism , 2014, Journal of Inherited Metabolic Disease.

[6]  H. Said,et al.  Adaptive regulation of human intestinal thiamine uptake by extracellular substrate level: a role for THTR-2 transcriptional regulation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[7]  Paul J Thornalley,et al.  Glucose-Induced Down Regulation of Thiamine Transporters in the Kidney Proximal Tubular Epithelium Produces Thiamine Insufficiency in Diabetes , 2012, PloS one.

[8]  H. Moradi,et al.  Effect of chronic kidney disease on the expression of thiamin and folic acid transporters. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Hitoshi Suzuki,et al.  Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. , 2009, The New England journal of medicine.

[10]  Elena Berrone,et al.  Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine , 2009, Diabetes/metabolism research and reviews.

[11]  M. Porta,et al.  Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications , 2008, Acta Diabetologica.

[12]  R. Babaei-Jadidi,et al.  High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease , 2007, Diabetologia.

[13]  N. Vaziri,et al.  Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE‐19) cells: mechanism and regulation , 2007, The Journal of physiology.

[14]  Elena Berrone,et al.  Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose* , 2006, Journal of Biological Chemistry.

[15]  C. Ricketts,et al.  Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. , 2006, Acta paediatrica.

[16]  H. Said,et al.  Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[17]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[18]  H. Said,et al.  In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2. , 2003, American journal of physiology. Cell physiology.

[19]  R. Babaei-Jadidi,et al.  Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. , 2003, Diabetes.

[20]  Xin Lu,et al.  Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. , 2003, Molecular cancer research : MCR.

[21]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[22]  M. O'hare,et al.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.

[23]  A. Albert,et al.  Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. , 2001, Diabetes care.

[24]  E. Neufeld,et al.  Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. , 2001, Blood cells, molecules & diseases.

[25]  B. Wlodarczyk,et al.  Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. , 2000, Molecular genetics and metabolism.

[26]  G. Rindi,et al.  Thiamine Intestinal Transport and Related Issues: Recent Aspects , 2000 .

[27]  G. Rindi,et al.  Transport of thiamin in rat renal brush border membrane vesicles. , 2000, Kidney international.

[28]  G. Camussi,et al.  HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. , 1998, The Journal of clinical investigation.

[29]  G. Gascon,et al.  Biotin-responsive basal ganglia disease: a novel entity. , 1998, Brain : a journal of neurology.

[30]  M. Porta,et al.  Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions , 1996, Diabetologia.

[31]  The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial , 1996, Diabetes.

[32]  J. E. Buttery,et al.  A Stable Reagent Mixture for the Whole Blood Transketolase Assay , 1996, Annals of clinical biochemistry.

[33]  The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. , 1996, Diabetes.